![\"\"](\"https:\/\/info.zanet.biz\/wp\/wp-content\/uploads\/2021\/12\/rel-to-abst-2-1024x463.png\")
<\/figure><\/li><\/ul>\u56f31\uff0e\u76f8\u5bfe\u7684\u52b9\u679c\u6307\u6a19\u304b\u3089\u7d76\u5bfe\u52b9\u679c\u3092\u6c42\u3081\u308b\u3002<\/figcaption><\/figure>\n\n\n\n <\/p>\n<\/div>\n<\/div>\n\n\n\n
\u76ca\u3068\u5bb3\u306e\u30d0\u30e9\u30f3\u30b9\u3042\u308b\u3044\u306f\u6b63\u5473\u306e\u76ca\u3001\u7d76\u5bfe\u52b9\u679c\u3001\u7d76\u5bfe\u30ea\u30b9\u30af\u3001\u30d9\u30fc\u30b9\u30e9\u30a4\u30f3\u30ea\u30b9\u30af\u3001\u30cf\u30b6\u30fc\u30c9\u7387\u3068\u30cf\u30b6\u30fc\u30c9\u6bd4\u3068\u30a4\u30d9\u30f3\u30c8\u7387\u3001\u30a2\u30a6\u30c8\u30ab\u30e0\u306e\u91cd\u8981\u6027\u3068\u4fa1\u5024\u89b3\u3001\u3053\u308c\u3089\u306b\u3064\u3044\u3066\u7406\u89e3\u3057\u305f\u3046\u3048\u3067\u3001Multi-Criteria Decision Analysis \uff08MCDA\uff09\u591a\u57fa\u6e96\u6c7a\u65ad\u5206\u6790\u3001Quantitative Benefit-Risk Analysis\u3042\u308b\u3044\u306fQuantitative-Benefit Harm Analysis\u5b9a\u91cf\u7684\u306a\u76ca\u3068\u5bb3\u306e\u5206\u6790\u306b\u3064\u3044\u3066\u7406\u89e3\u3059\u308b\u3053\u3068\u306f\u3001\u63a8\u5968\u4f5c\u6210\u306b\u304a\u3044\u3066\u4eca\u5f8c\u3088\u308a\u91cd\u8981\u306b\u306a\u308b\u3068\u601d\u3044\u307e\u3059\u3002 \u5b9a\u91cf\u7684\u306a\u76ca\u3068\u5bb3\u306e\u5206\u6790\u306b\u3064\u3044\u3066 \u306f\u3001\u3059\u3067\u306b\u3053\u308c\u307e\u3067\u89e3\u8aac\u3057\u3066\u304d\u307e\u3057\u305f\u304c\u3001\u307e\u3060\u89e3\u8aac\u3057\u3066\u3044\u306a\u3044Gail\/NCI\u306e\u65b9\u6cd5\u3082\u542b\u3081\u3066\u3001\u3088\u308a\u7dcf\u5408\u7684\u306b\u308f\u304b\u308a\u3084\u3059\u304f\u89e3\u8aac\u3057\u305f\u3044\u3068\u601d\u3063\u3066\u3044\u307e\u3059\u3002\u4eca\u56de\u306f\u3001\u56f31\u3068\u56f32\u3092\u3069\u3053\u307e\u3067\u7406\u89e3\u3067\u304d\u308b\u304b\u3001\u8003\u3048\u3066\u307f\u3066\u304f\u3060\u3055\u3044\u3002<\/p>\n\n\n\n
\n\n\n\n\n\n![\"\"](\"https:\/\/info.zanet.biz\/wp\/wp-content\/uploads\/2021\/12\/gail-nci-2-1024x626.png\")
<\/figure><\/li><\/ul>\u56f32\uff0eGail\/NCI\u306e\u65b9\u6cd5\u3002<\/figcaption><\/figure>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n - Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V: Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. <\/strong>J Natl Cancer Inst 1999;91:1829-46. PMID: 10547390<\/a> <\/li><\/ul>\n\n\n\n
- Multi-Criteria Decision Analysis \uff08MDCA\uff09><\/a><\/li>
- Multi-Criteria Decision Analysis (MCDA)\u306e\u30b9\u30c6\u30c3\u30d7 ><\/a><\/li>
- Keeney and Raiffa\u306eSwing weighting\u3092\u7528\u3044\u305fMCDA ><\/a><\/li>
- Swing weighting\u3092\u7528\u3044\u305fMCDA\u306e\u7d50\u679c ><\/a><\/li>
- EMA\u306eBenefit-risk methodology ><\/a><\/li>
- FDA\u306eBenefit-Risk Assessment Framework ><\/a><\/li>
- FDA\u306eBenefit-Risk Assessment\uff08\u7d9a\u304d\uff09 ><\/a><\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"
GRADE\u30a2\u30d7\u30ed\u30fc\u30c1\u3067\u306f\u30a8\u30d3\u30c7\u30f3\u30b9\u8a55\u4fa1\u306e\u307e\u3068\u3081\u3068\u3057\u3066\u3001”Evidence profile”\u3068\u3001\u3055\u3089\u306b”SoF (Summary of Findings) table”\u3092\u4f5c\u6210 … “SoF table\u304b\u3089\u6b63\u5473\u306e\u76ca Net benefit\u306e\u5206\u6790\u3078-1” \u306e<\/span>\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27,5,3,6],"tags":[],"class_list":["post-1047","post","type-post","status-publish","format-standard","hentry","category-benefit-harm-assessment","category-cpg","category-mdm","category-sdm"],"_links":{"self":[{"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/posts\/1047","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1047"}],"version-history":[{"count":12,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/posts\/1047\/revisions"}],"predecessor-version":[{"id":1073,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/posts\/1047\/revisions\/1073"}],"wp:attachment":[{"href":"https:\/\/info.zanet.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1047"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1047"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1047"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
- Multi-Criteria Decision Analysis (MCDA)\u306e\u30b9\u30c6\u30c3\u30d7 ><\/a><\/li>
- Multi-Criteria Decision Analysis \uff08MDCA\uff09><\/a><\/li>
- Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V: Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. <\/strong>J Natl Cancer Inst 1999;91:1829-46. PMID: 10547390<\/a> <\/li><\/ul>\n\n\n\n